8-K//Current report
Viracta Therapeutics, Inc. 8-K
Accession 0000950170-25-014630
$VIRXCIK 0001061027operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:00 PM ET
Size
177.1 KB
Accession
0000950170-25-014630
Documents
- 8-Kvirx-20250203.htmPrimary
8-K
- EX-99.1virx-ex99_1.htm
EX-99.1
- EX-101.SCHvirx-20250203.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-014630-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLvirx-20250203_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001061027
Filing Metadata
- Form type
- 8-K
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:00 PM ET
- Size
- 177.1 KB